Bodal Chemicals Zukünftiges Wachstum
Future Kriterienprüfungen 4/6
Bodal Chemicals wird ein jährliches Gewinn- und Umsatzwachstum von 98.1% bzw. 14.3% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 98.8% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 7.1% betragen.
Wichtige Informationen
98.1%
Wachstumsrate der Gewinne
98.8%
EPS-Wachstumsrate
| Chemicals Gewinnwachstum | 22.8% |
| Wachstumsrate der Einnahmen | 14.3% |
| Zukünftige Eigenkapitalrendite | 7.1% |
| Analystenabdeckung | Low |
| Zuletzt aktualisiert | 15 Nov 2024 |
Jüngste Aktualisierungen zum künftigen Wachstum
Recent updates
We Think Shareholders May Want To Consider A Review Of Bodal Chemicals Limited's (NSE:BODALCHEM) CEO Compensation Package
Sep 18
When Should You Buy Bodal Chemicals Limited (NSE:BODALCHEM)?
Apr 04Need To Know: This Analyst Just Made A Substantial Cut To Their Bodal Chemicals Limited (NSE:BODALCHEM) Estimates
Aug 18Increases to Bodal Chemicals Limited's (NSE:BODALCHEM) CEO Compensation Might Cool off for now
Sep 20Bodal Chemicals' (NSE:BODALCHEM) Dividend Will Be ₹0.80
Sep 04Is Bodal Chemicals (NSE:BODALCHEM) A Risky Investment?
Jul 23Is Bodal Chemicals (NSE:BODALCHEM) A Risky Investment?
Jan 13Bodal Chemicals (NSE:BODALCHEM) Has A Somewhat Strained Balance Sheet
Jul 18Should You Investigate Bodal Chemicals Limited (NSE:BODALCHEM) At ₹95.80?
Apr 08Bodal Chemicals Limited's (NSE:BODALCHEM) Stock Is Rallying But Financials Look Ambiguous: Will The Momentum Continue?
Mar 21These 4 Measures Indicate That Bodal Chemicals (NSE:BODALCHEM) Is Using Debt Extensively
Mar 06How Is Bodal Chemicals' (NSE:BODALCHEM) CEO Compensated?
Feb 19Is Bodal Chemicals Limited (NSE:BODALCHEM) A Great Dividend Stock?
Feb 06
What Percentage Of Bodal Chemicals Limited (NSE:BODALCHEM) Shares Do Insiders Own?
Jan 22Would Shareholders Who Purchased Bodal Chemicals' (NSE:BODALCHEM) Stock Three Years Be Happy With The Share price Today?
Jan 06Are Insiders Buying Bodal Chemicals Limited (NSE:BODALCHEM) Stock?
Dec 22Bodal Chemicals Limited (NSE:BODALCHEM) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies Ahead ?
Dec 07Here's Why Bodal Chemicals (NSE:BODALCHEM) Has A Meaningful Debt Burden
Nov 22Is Bodal Chemicals Limited (NSE:BODALCHEM) A Strong Dividend Stock?
Nov 07Is Bodal Chemicals (NSE:BODALCHEM) Likely To Turn Things Around?
Oct 13What You Need To Know About Bodal Chemicals Limited's (NSE:BODALCHEM) Investor Composition
Sep 25Who Has Been Buying Bodal Chemicals Limited (NSE:BODALCHEM) Shares?
Sep 09If You Had Bought Bodal Chemicals (NSE:BODALCHEM) Stock Five Years Ago, You Could Pocket A 144% Gain Today
Aug 25Bodal Chemicals (NSE:BODALCHEM) Has A Somewhat Strained Balance Sheet
Aug 10What Did Bodal Chemicals' (NSE:BODALCHEM) CEO Take Home Last Year?
Aug 10Should Bodal Chemicals Limited (NSE:BODALCHEM) Be Part Of Your Income Portfolio?
Jul 29Bodal Chemicals Limited's (NSE:BODALCHEM) Shares May Have Run Too Fast Too Soon
Jul 14Gewinn- und Umsatzwachstumsprognosen
| Datum | Umsatz | Gewinne | Freier Cashflow | Bargeld aus operativen Tätigkeiten | Durchschn. Anz. Analysten |
|---|---|---|---|---|---|
| 3/31/2027 | 22,803 | 934 | 730 | 1,721 | 1 |
| 3/31/2026 | 19,431 | 616 | 477 | 1,484 | 2 |
| 3/31/2025 | 17,399 | 39 | 620 | 1,388 | 1 |
| 9/30/2024 | 15,756 | 16 | 937 | 2,131 | N/A |
| 6/30/2024 | 14,841 | 31 | N/A | N/A | N/A |
| 3/31/2024 | 13,946 | 65 | -407 | 2,042 | N/A |
| 12/31/2023 | 13,906 | 72 | N/A | N/A | N/A |
| 9/30/2023 | 13,728 | 87 | -477 | 2,062 | N/A |
| 6/30/2023 | 14,440 | 177 | N/A | N/A | N/A |
| 3/31/2023 | 15,743 | 380 | -479 | 2,899 | N/A |
| 12/31/2022 | 17,678 | 676 | N/A | N/A | N/A |
| 9/30/2022 | 20,138 | 896 | -2,157 | 1,101 | N/A |
| 6/30/2022 | 20,878 | 1,030 | N/A | N/A | N/A |
| 3/31/2022 | 20,553 | 1,042 | -1,726 | -135 | N/A |
| 12/31/2021 | 18,861 | 1,004 | N/A | N/A | N/A |
| 9/30/2021 | 16,904 | 1,052 | -2,713 | -355 | N/A |
| 6/30/2021 | 15,304 | 916 | N/A | N/A | N/A |
| 3/31/2021 | 12,264 | 420 | -1,911 | -130 | N/A |
| 12/31/2020 | 11,622 | 418 | N/A | N/A | N/A |
| 9/30/2020 | 11,224 | 297 | 677 | 1,198 | N/A |
| 6/30/2020 | 11,204 | 406 | N/A | N/A | N/A |
| 3/31/2020 | 13,748 | 872 | -425 | 96 | N/A |
| 12/31/2019 | 13,506 | 941 | N/A | N/A | N/A |
| 9/30/2019 | 13,586 | 1,091 | -1,367 | 115 | N/A |
| 6/30/2019 | 14,441 | 1,323 | N/A | N/A | N/A |
| 3/31/2019 | 14,235 | 1,432 | 377 | 1,860 | N/A |
| 12/31/2018 | 13,725 | 1,528 | N/A | N/A | N/A |
| 9/30/2018 | 13,454 | 1,527 | N/A | N/A | N/A |
| 6/30/2018 | 12,083 | 1,321 | N/A | N/A | N/A |
| 3/31/2018 | 11,422 | 1,226 | N/A | 71 | N/A |
| 3/31/2017 | 12,344 | 1,329 | N/A | 1,036 | N/A |
| 3/31/2016 | 9,078 | 860 | N/A | 1,312 | N/A |
| 3/31/2015 | 10,443 | 918 | N/A | 1,977 | N/A |
| 3/31/2014 | 9,496 | 302 | N/A | 492 | N/A |
Analystenprognosen zum zukünftigen Wachstum
Einkommen vs. Sparrate: BODALCHEMDas prognostizierte Gewinnwachstum (98.1% pro Jahr) liegt über der Sparquote (6.7%).
Ertrag vs. Markt: BODALCHEMDie Erträge des Unternehmens (98.1% pro Jahr) werden voraussichtlich schneller wachsen als der Markt Indian (18.1% pro Jahr).
Hohe Wachstumserträge: BODALCHEMEs wird erwartet, dass die Erträge des Unternehmens in den nächsten 3 Jahren erheblich steigen werden.
Einnahmen vs. Markt: BODALCHEMDie Einnahmen des Unternehmens (14.3% pro Jahr) werden voraussichtlich schneller wachsen als der Markt Indian (10.5% pro Jahr).
Hohe Wachstumseinnahmen: BODALCHEMDie Einnahmen des Unternehmens (14.3% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.
Wachstumsprognosen für den Gewinn je Aktie
Künftige Eigenkapitalrendite
Künftige Eigenkapitalrendite: BODALCHEMDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (7.1%).